cytidine has been researched along with tretinoin in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mejer, J; Mortensen, BT | 1 |
| Bierau, J; Caron, HN; Leen, R; van Gennip, AH; van Kuilenburg, AB | 1 |
| Borutinskaite, VV; Bruzaite, R; Jonusiene, V; Navakauskiene, R; Savickiene, J; Treigyte, G | 1 |
| Borutinskaite, VV; Navakauskiene, R; Savickiene, J; Treigyte, G | 1 |
| Clayton, RN; Duong, CV; Farrell, WE; Yacqub-Usman, K | 1 |
| Czupryn, A; Deptuła, M; Filipowicz, N; Górnikiewicz, B; Janus, Ł; Kamińska, J; Mieczkowska, A; Mucha, P; Nowicka, E; Peszyńska-Sularz, G; Pikuła, M; Piotrowski, A; Podolak-Popinigis, J; Rekowski, P; Rodziewicz-Motowidło, S; Rogujski, P; Ruczyński, J; Sachadyn, P; Sass, P; Skowron, P; Sosnowski, P; Wardowska, A | 1 |
6 other study(ies) available for cytidine and tretinoin
| Article | Year |
|---|---|
Reduction of ara-C cytotoxicity in HL 60 cells by addition of deoxycytidine, cytidine or increased level of cytidine deaminase.
Topics: Bone Marrow; Bone Marrow Cells; Cell Division; Cytarabine; Cytidine; Cytidine Deaminase; Deoxycytidine; Deoxycytidine Kinase; Humans; Leukemia, Promyelocytic, Acute; Nucleoside Deaminases; Phosphotransferases; Tetrahydrouridine; Tretinoin; Tumor Cells, Cultured | 1989 |
Retinoic acid reduces the cytotoxicity of cyclopentenyl cytosine in neuroblastoma cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Differentiation; Cell Division; Cytidine; Cytidine Triphosphate; Drug Interactions; Humans; Neuroblastoma; Polyphosphates; Tretinoin; Tumor Cells, Cultured | 2002 |
Epigenetic changes by zebularine leading to enhanced differentiation of human promyelocytic leukemia NB4 and KG1 cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Differentiation; Cell Line, Tumor; Cytidine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; Dose-Response Relationship, Drug; Drug Synergism; Epigenesis, Genetic; Humans; Leukemia, Promyelocytic, Acute; Tretinoin | 2012 |
Antileukemic activity of combined epigenetic agents, DNMT inhibitors zebularine and RG108 with HDAC inhibitors, against promyelocytic leukemia HL-60 cells.
Topics: Acetylation; Cadherins; CD11b Antigen; Cell Differentiation; Cell Proliferation; CpG Islands; Cytidine; Enzyme Inhibitors; Epigenesis, Genetic; Histone Deacetylase Inhibitors; Histones; HL-60 Cells; Humans; Indoles; Leukemia, Promyelocytic, Acute; Methylation; Phthalimides; Promoter Regions, Genetic; Propionates; Tretinoin; Tryptophan | 2012 |
Preincubation of pituitary tumor cells with the epidrugs zebularine and trichostatin A are permissive for retinoic acid-augmented expression of the BMP-4 and D2R genes.
Topics: Adenoma; Animals; Bone Morphogenetic Protein 4; Cell Culture Techniques; Cytidine; Drug Synergism; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Mice; Pituitary Neoplasms; Prodrugs; Receptors, Dopamine D2; Time Factors; Tretinoin; Tumor Cells, Cultured | 2013 |
Epigenetic inhibitor zebularine activates ear pinna wound closure in the mouse.
Topics: Animals; Biomarkers; Cell Proliferation; CpG Islands; Cytidine; DNA Methylation; Ear Auricle; Epigenesis, Genetic; Keratinocytes; Mice; Regenerative Medicine; Tretinoin; Wound Healing | 2019 |